Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA)

Completed · Phase 1/Phase 2

Conditions studied: Leber Congenital Amaurosis

In brief

A clinical trial of AAV2/5 vector for patients with Defects in RPE65

Key facts

Study ID

NCT02781480

Run by

MeiraGTx UK II Ltd

People needed

15

Starts

2016-04-01

Expected to finish

2018-12-01

Last updated by the study team

2021-07-12

Who can join

Age: 3 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Kellogg Eye Centre, University of Michigan — Ann Arbor, Michigan, United States
• Moorfields Eye Hospital NHS Foundation Trust — London, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.